Home
Sweden
Living
World
Business
Sports
Entertainment
Info
Sweden
Living
World
Business
Sports
Entertainment
EU:s läkemedelsmyndighet
EU Approves Alzheimer's Drug Lecanemab for Sale
The Alzheimer's drug lecanemab has been granted permission by the EU Commission for sale within the union as well as in Iceland, Liechtenstein, and Norway, announces the Swedish company Bioarctic in a press release. The permission is given since EMA, the EU's pharmaceutical authority, approved lecanemab last winter.
Not just war: Nine things to look forward to in 2024
2024 was marked by war, misery, and brutal death. But there were glimmers of light.
Long wait for new Alzheimer's drug
After years of waiting, the message came: the EU's pharmaceutical authority says yes to the drug lecanemab against Alzheimer's. But the question is which patients can be treated, and when – and if it is introduced in the country's regions at all.
Not just war: Nine things to look forward to in 2024
2024 was marked by war, misery, and brutal death. But there were glimmers of light.
EMA's turnaround: Approves Alzheimer's drug
The disappointment was great when a new Alzheimer's drug was rejected by the EU's pharmaceutical authority (EMA) last summer. But now EMA has reconsidered its statement – and approves the sale of the drug lecanemab for the treatment of certain Alzheimer's patients.
1
Facebook
X
Instagram
Show Consent Options
Categories
Sweden
Living
World
Business
Sports
Entertainment
Police reports
Information
Publishing principles
Cookiepolicy
Datapolicy
Weather forecast
Current time in Sweden
About us
Contact
About Sweden Herald
Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
© Sweden Herald